Patents by Inventor Roger Fleming

Roger Fleming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9383351
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: July 5, 2016
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Roger Fleming
  • Publication number: 20140329258
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Application
    Filed: July 15, 2014
    Publication date: November 6, 2014
    Inventor: Roger Fleming
  • Patent number: 8815607
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 26, 2014
    Assignee: Bayer Healthcare LLC
    Inventor: Roger Fleming
  • Patent number: 8691161
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: April 8, 2014
    Assignee: Bayer HealthCare LLC
    Inventor: Roger Fleming
  • Publication number: 20140093895
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Application
    Filed: December 4, 2013
    Publication date: April 3, 2014
    Applicant: Bayer HealthCare LLC
    Inventor: Roger Fleming
  • Publication number: 20080118399
    Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.
    Type: Application
    Filed: December 12, 2005
    Publication date: May 22, 2008
    Inventor: Roger Fleming
  • Patent number: 6450222
    Abstract: A non-pneumatic tire having an elastomeric portion encompassing the tread and a radially inward foam portion. In the elastomeric portion, certain physical characteristics of the elastomeric portion differ between the tread surface and the radially inward region. An increase in the Shore A hardness provides the tire structure with an elastomeric hoop which imparts improved rolling resistance to the tire, without compromising wet/dry traction. Likewise, the weight and compliance of the tire may be adjusted in the foam portion without adverse effects on the rolling resistance. The non-pneumatic tire may be formed from a multi-shot process in a spin cast procedure.
    Type: Grant
    Filed: July 14, 1999
    Date of Patent: September 17, 2002
    Inventor: Roger Fleming
  • Patent number: 4766080
    Abstract: A method for the quantitative determination of lithium in a liquid test sample employing turbidimetric or nephelometric techniques to measure the maximum rate of change in the optical density of a reaction mixture containing precipitated lithium. The lithium is precipitated by a lithium precipitating reagent to result in dispersed, suspended particles, and the maximum rate of change in optical density determined to provide a linear dose response which can be quantitatively correlated to the amount of lithium present in the test sample.
    Type: Grant
    Filed: August 28, 1987
    Date of Patent: August 23, 1988
    Assignee: Miles Inc.
    Inventor: Roger Fleming